Administration of polypeptide growth factors following...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 38/19 (2006.01)

Patent

CA 2249368

The present invention relates to the treatment of central nervous system injuries by intracisternal or intravenous administration of polypeptide growth factors, such as basic fibroblast growth factor. This method provides significant benefits because administration can occur a substantial amount of time following an injury.

L'invention concerne le traitement de lésions du système nerveux central par l'administration intra-occipitale ou intraveineuse de facteurs de croissance polypeptidiques, tels qu'un facteur de base de croissance de fibroblastes. Ce procédé présente des avantages importants, étant donné qu'on peut effectuer l'administration après une durée passablement longue suivant la lésion.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Administration of polypeptide growth factors following... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of polypeptide growth factors following..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of polypeptide growth factors following... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1806527

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.